Results
1 -
10 of
90
(Click
here to explore results)
Cross-species biosynthesis of maytansine in Maytenus serrata . Parijat Kusari, Souvik Kusari, Dennis Eckelmann, Sebastian Zühlke, Oliver Kayser, Michael Spiteller
, RSC Adv.
, 2016
, 6
, 10011
Targeted delivery of maytansine to liver cancer cells via galactose-modified supramolecular two-dimensional glycomaterial . Hai-Na Xie, Yu-Yuan Chen, Guo-Biao Zhu, Hai-Hao Han, Xi-Le Hu, Zhi-Qiang Pan, Yi Zang, Dong-Hao Xie, Xiao-Peng He, Jia Li, Tony D. James
, Chem. Commun.
, 2022
, 58
, 5029
The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics . Hans-Peter Gerber, Frank E. Koehn, Robert T. Abraham
, Nat. Prod. Rep.
, 2013
, 30
, 625
Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates . Thomas H. Pillow, Jack D. Sadowsky, Donglu Zhang, Shang-Fan Yu, Geoffrey Del Rosario, Keyang Xu, Jintang He, Sunil Bhakta, Rachana Ohri, Katherine R. Kozak, Edward Ha, Jagath R. Junutula, John A. Flygare
, Chem. Sci.
, 2017
, 8
, 366
Transforming a highly toxic agent DM1 into injectable safe nanomedicines via prodrug self-assembly for the treatment of taxane-resistant cancer . Jiangling Huang, Shanshan Song, Min Wang, Hangxiang Wang
, Nanoscale
, 2023
, 15
, 10110
Structural diversity and biological relevance of benzenoid and atypical ansamycins and their congeners . Natalia Skrzypczak, Piotr Przybylski
, Nat. Prod. Rep.
, 2022
, 39
, 1678
Recognition of arylmethylidene derivatives of imidazothiazolotriazinones as novel tubulin polymerization inhibitors . Alexei N. Izmest'ev, Elena V. Svirshchevskaya, Sergey B. Akopov, Angelina N. Kravchenko, Galina A. Gazieva
, RSC Med. Chem.
, 2024
, 15
, 1258
Crystal and molecular structure and absolute configuration of maytansine (3-bromopropyl) ether . Robert F. Bryan, Christopher J. Gilmore, R. Curtis Haltiwanger
, J. Chem. Soc., Perkin Trans. 2
, 1973
, 897
Albumin nanoparticle encapsulation of potent cytotoxic therapeutics shows sustained drug release and alleviates cancer drug toxicity . Hangxiang Wang, Jiaping Wu, Li Xu, Ke Xie, Chao Chen, Yuehan Dong
, Chem. Commun.
, 2017
, 53
, 2618
Site-selective modification strategies in antibody–drug conjugates . Stephen J. Walsh, Jonathan D. Bargh, Friederike M. Dannheim, Abigail R. Hanby, Hikaru Seki, Andrew J. Counsell, Xiaoxu Ou, Elaine Fowler, Nicola Ashman, Yuri Takada, Albert Isidro-Llobet, Jeremy S. Parker, Jason S. Carroll, David R. Spring
, Chem. Soc. Rev.
, 2021
, 50
, 1305